Matouk Bassiouny & Hennawy (MBH) advised Triquera, the majority shareholder of Minapharm Pharmaceuticals, in connection with the subscription of a minority stake by Admaius Capital Partners (Admaius), a private equity investor with a
Matouk Bassiouny & Hennawy (MBH) advised Triquera, the majority shareholder of Minapharm Pharmaceuticals, in connection with the subscription of a minority stake by Admaius Capital Partners (Admaius), a private equity investor with a